| RS138491809 |
GHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Laron-type isolated somatotropin defect, Laron-type isolated somatotropin defect |
| RS1384922524 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS138492835 |
NSDHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Connective tissue disorder |
| RS138492927 |
HK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1384933966 |
TMPRSS6
|
Health Risk |
Likely pathogenic |
Iron-refractory iron deficiency anemia, Iron-refractory iron deficiency anemia |
| RS138493551 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS138493915 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Inborn genetic diseases |
| RS138495222 |
EXT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Exostoses, multiple |
| RS138495345 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease 2 |
| RS138495618 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138495705 |
FLVCR2
|
Health Risk |
Pathogenic |
Fowler syndrome, Fowler syndrome |
| RS138496114 |
NES
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1384962507 |
P3H2
|
Health Risk |
Pathogenic |
— |
| RS138497004 |
GUCY2C
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138497378 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS138497409 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1384974578 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS1384976053 |
BRAT1
|
Health Risk |
Pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS138497710 |
GLIS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Neonatal diabetes mellitus with congenital hypothyroidism |
| RS138497939 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS138498207 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital long QT syndrome, Long QT syndrome |
| RS138498376 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Acute febrile neutrophilic dermatosis |
| RS138498390 |
PDYN
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 23, Spinocerebellar ataxia type 23 |
| RS138498426 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gaucher disease type I, Gaucher disease type II |
| RS138498551 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1384985862 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS138498898 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Avascular necrosis of femoral head, primary |
| RS138499176 |
FBXO11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138499457 |
PIEZO2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138500508 |
FASTKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation deficiency 44, Inborn genetic diseases |
| RS138500615 |
VLDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
VLDLR-related disorder, VLDLR-related disorder |
| RS1385011604 |
PIGQ
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, Inborn genetic diseases |
| RS138501547 |
CTNNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138501598 |
XPNPEP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis-like nephropathy 1, Inborn genetic diseases |
| RS138502867 |
IMPDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
IMPDH1-related disorder, IMPDH1-related disorder |
| RS138503809 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperparathyroidism 1, Hyperparathyroidism 2 with jaw tumors |
| RS138503916 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
COL4A1-related disorder, Inborn genetic diseases |
| RS138503921 |
ALOX12B
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 2, Autosomal recessive congenital ichthyosis 2 |
| RS138504099 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, ABCA12-related disorder |
| RS138504221 |
SGSH
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS138504338 |
ELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Supravalvar aortic stenosis, Inborn genetic diseases |
| RS138504371 |
CBLIF
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary intrinsic factor deficiency, Hereditary intrinsic factor deficiency |
| RS1385050944 |
COL4A2
|
Health Risk |
Pathogenic |
— |
| RS138505566 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS138505797 |
PRKCSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic liver disease 1, Polycystic liver disease 1 |
| RS1385058993 |
MEIS2
|
Health Risk |
Likely pathogenic |
Cardiac malformation, cleft lip/palate |
| RS138506461 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS138506849 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS138507620 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1385076821 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS138507814 |
GHSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature due to growth hormone secretagogue receptor deficiency, Short stature due to growth hormone secretagogue receptor deficiency |
| RS138508233 |
ODAD2
|
Health Risk |
Pathogenic |
— |
| RS138508512 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS138509345 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138509553 |
TMEM237
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 14, TMEM237-related disorder |
| RS138509814 |
C5
|
Health Risk |
Conflicting classifications of pathogenicity |
Complement component 5 deficiency, Eculizumab |
| RS138509817 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1385101139 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS138510486 |
ESRRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 35, Autosomal recessive nonsyndromic hearing loss 35 |
| RS1385106410 |
COL4A3
|
Health Risk |
Likely pathogenic |
Alport syndrome, Autosomal dominant Alport syndrome |
| RS138510668 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Familial dysautonomia |
| RS1385107002 |
NT5C2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 45, Hereditary spastic paraplegia 45 |
| RS138510884 |
GOSR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy, Inborn genetic diseases |
| RS138511291 |
KCNJ10
|
Health Risk |
Conflicting classifications of pathogenicity |
EAST syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS138511448 |
DNAAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 10 |
| RS138511699 |
FGG
|
Health Risk |
Conflicting classifications of pathogenicity |
Abnormal bleeding, Congenital afibrinogenemia |
| RS1385119665 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, ABCA4-related disorder |
| RS138511988 |
IFT172
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 71, Short-rib thoracic dysplasia 10 with or without polydactyly |
| RS1385129513 |
SCLT1
|
Health Risk |
Likely pathogenic |
— |
| RS1385130088 |
HPS5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome 5 |
| RS1385132304 |
KCNV2
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1385139268 |
TPO
|
Health Risk |
Likely pathogenic |
Congenital hypothyroidism, Congenital hypothyroidism |
| RS138514054 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1385141619 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1385142974 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS138514430 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, NLRP12-related disorder |
| RS1385146569 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS138515091 |
BSCL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe neurodegenerative syndrome with lipodystrophy, Charcot-Marie-Tooth disease type 2 |
| RS138515760 |
PHGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
PHGDH deficiency, Inborn genetic diseases |
| RS138517528 |
DNHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
DNHD1-related disorder, DNHD1-related disorder |
| RS138517537 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cortical dysplasia-focal epilepsy syndrome, Inborn genetic diseases |
| RS138518139 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138518242 |
COG5
|
Health Risk |
Conflicting classifications of pathogenicity |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS138518245 |
GALE
|
Health Risk |
Conflicting classifications of pathogenicity |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS138519099 |
DPAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
DPAGT1-congenital disorder of glycosylation, Congenital myasthenic syndrome 13 |
| RS138519217 |
ZNF408
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138520154 |
KCNJ16
|
Health Risk |
Pathogenic |
Hypokalemic tubulopathy and deafness, Hypokalemic tubulopathy and deafness |
| RS138520224 |
KDM5C
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS1385213836 |
BTD
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotinidase deficiency, Biotinidase deficiency |
| RS138521550 |
HADH
|
Health Risk |
Likely pathogenic |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Hyperinsulinemic hypoglycemia |
| RS138521721 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperinsulinism, Maturity-onset diabetes of the young |
| RS138521935 |
ATP2B4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138522639 |
SEMA3C
|
Health Risk |
Conflicting classifications of pathogenicity |
SEMA3C-related disorder, SEMA3C-related disorder |
| RS1385227341 |
CYP26C1
|
Health Risk |
Pathogenic |
— |
| RS138523651 |
MEGF10
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS138524783 |
LAMA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Laryngo-onycho-cutaneous syndrome, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1385251852 |
HNF4A
|
Health Risk |
Likely pathogenic/Likely risk allele |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young |
| RS138525539 |
ADGRA3
|
Health Risk |
Conflicting classifications of pathogenicity |
ADGRA3-related disorder, ADGRA3-related disorder |
| RS138526426 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 |
| RS138526888 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |